Volume 8; Issue 7

Main
Immunotherapy
Volume 8; Issue 7

Immunotherapy

Volume 8; Issue 7

1

Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?

Furness, Andrew JS, Quezada, Sergio A, Peggs, Karl S

Journal:

Year:

2016

Language:

english

File:

PDF, 1.48 MB

english, 2016

2

Immune checkpoint inhibitors side effects and management

Kourie, Hampig Raphael, Klastersky, Jean

Journal:

Year:

2016

Language:

english

File:

PDF, 1.64 MB

english, 2016

3

Part II: Checkpoint inhibitors in cancer therapy

Journal:

Year:

2016

Language:

english

File:

PDF, 1.40 MB

english, 2016

4

Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies

Janakiram, Murali, Pareek, Vipul, Cheng, Haiying, Narasimhulu, Deepa M, Zang, Xingxing

Journal:

Year:

2016

Language:

english

File:

PDF, 1.67 MB

english, 2016

5

Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges

Kyi, Chrisann, Postow, Michael A

Journal:

Year:

2016

Language:

english

File:

PDF, 1.92 MB

english, 2016

6

Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitors

Stahl, Maximilian, Gedrich, Richard, Peck, Ronald, LaVallee, Theresa, Eder, Joseph Paul

Journal:

Year:

2016

Language:

english

File:

PDF, 2.40 MB

english, 2016

7

Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma

Loo, Kimberly, Daud, Adil

Journal:

Year:

2016

Language:

english

File:

PDF, 1.79 MB

english, 2016

8

Checkpoint inhibitors for renal cell carcinoma: current landscape and future directions

Zibelman, Matthew, Ghatalia, Pooja, Geynisman, Daniel M, Plimack, Elizabeth R

Journal:

Year:

2016

Language:

english

File:

PDF, 1.56 MB

english, 2016